Published in ACS Chem Neurosci on April 16, 2012
HIV-1 transgenic female rat: synaptodendritic alterations of medium spiny neurons in the nucleus accumbens. J Neuroimmune Pharmacol (2014) 0.84
The guanine nucleotide exchange factor (GEF) Asef2 promotes dendritic spine formation via Rac activation and spinophilin-dependent targeting. J Biol Chem (2015) 0.76
"Pro-dopamine regulation (KB220Z™)" as a long-term therapeutic modality to overcome reduced resting state dopamine tone in opiate/opioid epidemic in America. J Syst Integr Neurosci (2016) 0.75
Dendritic spine geometry is critical for AMPA receptor expression in hippocampal CA1 pyramidal neurons. Nat Neurosci (2001) 8.55
Dendritic spine changes associated with hippocampal long-term synaptic plasticity. Nature (1999) 7.72
Rapid spine delivery and redistribution of AMPA receptors after synaptic NMDA receptor activation. Science (1999) 6.77
Rapid dendritic morphogenesis in CA1 hippocampal dendrites induced by synaptic activity. Science (1999) 6.08
Structural plasticity associated with exposure to drugs of abuse. Neuropharmacology (2004) 6.08
Addiction and the brain antireward system. Annu Rev Psychol (2008) 5.17
Structure-stability-function relationships of dendritic spines. Trends Neurosci (2003) 4.80
Stress, dysregulation of drug reward pathways, and the transition to drug dependence. Am J Psychiatry (2007) 4.37
Dendritic spines: structure, dynamics and regulation. Nat Rev Neurosci (2001) 3.57
LTP promotes formation of multiple spine synapses between a single axon terminal and a dendrite. Nature (1999) 3.55
Alterations in the morphology of dendrites and dendritic spines in the nucleus accumbens and prefrontal cortex following repeated treatment with amphetamine or cocaine. Eur J Neurosci (1999) 3.54
Ethanol inhibits NMDA-activated ion current in hippocampal neurons. Science (1989) 3.47
A key role for corticotropin-releasing factor in alcohol dependence. Trends Neurosci (2007) 3.16
Corticotropin-releasing factor within the central nucleus of the amygdala mediates enhanced ethanol self-administration in withdrawn, ethanol-dependent rats. J Neurosci (2006) 3.13
Neurotrophins and time: different roles for TrkB signaling in hippocampal long-term potentiation. Neuron (1997) 3.03
Alcoholism: a systems approach from molecular physiology to addictive behavior. Physiol Rev (2009) 2.82
Structure, development, and plasticity of dendritic spines. Curr Opin Neurobiol (1999) 2.74
Pharmacological evidence for a motivational role of kappa-opioid systems in ethanol dependence. Neuropsychopharmacology (2007) 2.61
The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors. Brain Res (2009) 2.61
Alcohol dependence is associated with blunted dopamine transmission in the ventral striatum. Biol Psychiatry (2005) 2.45
Cocaine self-administration alters the morphology of dendrites and dendritic spines in the nucleus accumbens and neocortex. Synapse (2001) 2.42
Glutamate receptors regulate actin-based plasticity in dendritic spines. Nat Neurosci (2000) 2.41
Overview on the structure, composition, function, development, and plasticity of hippocampal dendritic spines. Hippocampus (2000) 2.40
Profound decreases in dopamine release in striatum in detoxified alcoholics: possible orbitofrontal involvement. J Neurosci (2007) 2.38
The type 1 equilibrative nucleoside transporter regulates ethanol intoxication and preference. Nat Neurosci (2004) 2.33
The orexin system regulates alcohol-seeking in rats. Br J Pharmacol (2006) 2.30
Upregulation of voluntary alcohol intake, behavioral sensitivity to stress, and amygdala crhr1 expression following a history of dependence. Biol Psychiatry (2007) 2.29
Alcohol: effects on neurobehavioral functions and the brain. Neuropsychol Rev (2007) 2.20
The role of the dynorphin-kappa opioid system in the reinforcing effects of drugs of abuse. Psychopharmacology (Berl) (2010) 2.19
Drug addiction as dopamine-dependent associative learning disorder. Eur J Pharmacol (1999) 2.17
High levels of dopamine D2 receptors in unaffected members of alcoholic families: possible protective factors. Arch Gen Psychiatry (2006) 1.97
Specific alterations of extracellular endocannabinoid levels in the nucleus accumbens by ethanol, heroin, and cocaine self-administration. J Neurosci (2007) 1.81
Cortical gray matter loss in treatment-naïve alcohol dependent individuals. Alcohol Clin Exp Res (2002) 1.80
Effect of naltrexone and ondansetron on alcohol cue-induced activation of the ventral striatum in alcohol-dependent people. Arch Gen Psychiatry (2008) 1.80
Neurokinin 1 receptor antagonism as a possible therapy for alcoholism. Science (2008) 1.77
Stimulation of endorphin neurotransmission in the nucleus accumbens by ethanol, cocaine, and amphetamine. J Neurosci (2001) 1.75
Metabotropic glutamate receptor ligands as potential therapeutics for addiction. Curr Drug Abuse Rev (2009) 1.66
Degradation of association and projection white matter systems in alcoholism detected with quantitative fiber tracking. Biol Psychiatry (2008) 1.64
Ethanol increases extracellular adenosine by inhibiting adenosine uptake via the nucleoside transporter. J Biol Chem (1990) 1.63
Chronic alcohol neuroadaptation and stress contribute to susceptibility for alcohol craving and relapse. Pharmacol Ther (2010) 1.62
Ethanol increases glutamate neurotransmission in the posterior ventral tegmental area of female wistar rats. Alcohol Clin Exp Res (2011) 1.58
Profound decrement of mesolimbic dopaminergic neuronal activity during ethanol withdrawal syndrome in rats: electrophysiological and biochemical evidence. Proc Natl Acad Sci U S A (1993) 1.50
Neurobiological mechanisms of addiction: focus on corticotropin-releasing factor. Curr Opin Investig Drugs (2010) 1.49
The dopamine hypothesis of drug addiction: hypodopaminergic state. Int Rev Neurobiol (2005) 1.45
CRF-1 antagonist and CRF-2 agonist decrease binge-like ethanol drinking in C57BL/6J mice independent of the HPA axis. Neuropsychopharmacology (2010) 1.44
Blockade of the corticotropin releasing factor type 1 receptor attenuates elevated ethanol drinking associated with drinking in the dark procedures. Alcohol Clin Exp Res (2007) 1.43
The complexity of alcohol drinking: studies in rodent genetic models. Behav Genet (2010) 1.41
Systematic analysis of glutamatergic neurotransmission genes in alcohol dependence and adolescent risky drinking behavior. Arch Gen Psychiatry (2008) 1.39
Effector immediate-early gene arc in the amygdala plays a critical role in alcoholism. J Neurosci (2008) 1.32
Ethanol facilitates glutamatergic transmission to dopamine neurons in the ventral tegmental area. Neuropsychopharmacology (2008) 1.32
Direct measurement of glutamate release in the brain using a dual enzyme-based electrochemical sensor. Brain Res (1994) 1.32
Homeostatic plasticity during alcohol exposure promotes enlargement of dendritic spines. Eur J Neurosci (2006) 1.27
The endogenous opioid system: a common substrate in drug addiction. Drug Alcohol Depend (2009) 1.25
Alcohol inhibition of neurogenesis: a mechanism of hippocampal neurodegeneration in an adolescent alcohol abuse model. Hippocampus (2010) 1.24
Drugs for relapse prevention of alcoholism: ten years of progress. Trends Pharmacol Sci (2008) 1.23
Neuropeptide Y in the central nucleus of the amygdala suppresses dependence-induced increases in alcohol drinking. Pharmacol Biochem Behav (2008) 1.23
The thorny side of addiction: adaptive plasticity and dendritic spines. ScientificWorldJournal (2007) 1.22
Aberrant learning and memory in addiction. Neurobiol Learn Mem (2011) 1.19
A widespread distinct pattern of cerebral atrophy in patients with alcohol addiction revealed by voxel-based morphometry. J Neurol Neurosurg Psychiatry (2006) 1.19
Translating the neuroscience of alcoholism into clinical treatments: from blocking the buzz to curing the blues. Neurosci Biobehav Rev (2009) 1.18
Regulation of GABA(A) receptor subunit expression by pharmacological agents. Pharmacol Rev (2010) 1.18
Ethanol and brain plasticity: receptors and molecular networks of the postsynaptic density as targets of ethanol. Pharmacol Ther (2003) 1.18
Endogenous opioids and addiction to alcohol and other drugs of abuse. Curr Top Med Chem (2009) 1.18
Neurochemistry of drug action: insights from proton magnetic resonance spectroscopic imaging and their relevance to addiction. Ann N Y Acad Sci (2010) 1.17
Association between Val66Met brain-derived neurotrophic factor (BDNF) gene polymorphism and post-treatment relapse in alcohol dependence. Alcohol Clin Exp Res (2009) 1.16
Mechanistic studies of ethanol's interaction with the mesolimbic dopamine reward system. Pharmacopsychiatry (2009) 1.15
The persistence of maladaptive memory: addiction, drug memories and anti-relapse treatments. Neurosci Biobehav Rev (2012) 1.15
Compulsive alcohol drinking in rodents. Addict Biol (2009) 1.15
The dopamine D3 receptor is part of a homeostatic pathway regulating ethanol consumption. J Neurosci (2006) 1.15
Dysregulation of nociceptin/orphanin FQ activity in the amygdala is linked to excessive alcohol drinking in the rat. Biol Psychiatry (2008) 1.14
The decreased cellular expression of neuropeptide Y protein in rat brain structures during ethanol withdrawal after chronic ethanol exposure. Alcohol Clin Exp Res (2002) 1.13
Synaptic effects induced by alcohol. Curr Top Behav Neurosci (2013) 1.13
The dopamine D3 receptor plays an essential role in alcohol-seeking and relapse. FASEB J (2006) 1.12
GABAergic gene expression in postmortem hippocampus from alcoholics and cocaine addicts; corresponding findings in alcohol-naïve P and NP rats. PLoS One (2012) 1.12
Urocortin 1 microinjection into the mouse lateral septum regulates the acquisition and expression of alcohol consumption. Neuroscience (2007) 1.12
Chronic alcohol drinking alters neuronal dendritic spines in the brain reward center nucleus accumbens. Brain Res (2007) 1.11
Brain-derived neurotrophic factor alters the synaptic modification threshold in visual cortex. Neuropharmacology (1999) 1.11
Endocannabinoid system and alcohol addiction: pharmacological studies. Pharmacol Biochem Behav (2005) 1.09
Nicotine sensitization increases dendritic length and spine density in the nucleus accumbens and cingulate cortex. Brain Res (2001) 1.09
Effects of the mGlu2/3 agonist LY379268 and the mGlu5 antagonist MTEP on ethanol seeking and reinforcement are differentially altered in rats with a history of ethanol dependence. Biol Psychiatry (2010) 1.08
The dopamine hypothesis of drug addiction and its potential therapeutic value. Front Psychiatry (2011) 1.08
Type 1 equilibrative nucleoside transporter regulates ethanol drinking through accumbal N-methyl-D-aspartate receptor signaling. Biol Psychiatry (2011) 1.08
Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors. Pharmacol Ther (2011) 1.08
Role of mu and delta opioid receptors in alcohol drinking behaviour. Curr Drug Abuse Rev (2008) 1.06
A microdialysis profile of dynorphin A(1-8) release in the rat nucleus accumbens following alcohol administration. Alcohol Clin Exp Res (2006) 1.04
The endocannabinoid system tonically regulates inhibitory transmission and depresses the effect of ethanol in central amygdala. Neuropsychopharmacology (2010) 1.04
Beta-endorphin and drug-induced reward and reinforcement. Prog Neurobiol (2008) 1.04
Diolistic labeling of neuronal cultures and intact tissue using a hand-held gene gun. Nat Protoc (2006) 1.02
A caged Ab reveals an immediate/instructive effect of BDNF during hippocampal synaptic potentiation. Proc Natl Acad Sci U S A (2001) 1.02
Alcohol-seeking behavior is associated with increased glutamate transmission in basolateral amygdala and nucleus accumbens as measured by glutamate-oxidase-coated biosensors. Addict Biol (2010) 1.02
Differential effects of acute and chronic ethanol exposure on orexin expression in the perifornical lateral hypothalamus. Alcohol Clin Exp Res (2010) 1.01
Regulation of brain anandamide by acute administration of ethanol. Biochem J (2007) 0.99
Central neuropeptide Y modulates binge-like ethanol drinking in C57BL/6J mice via Y1 and Y2 receptors. Neuropsychopharmacology (2012) 0.99
Acamprosate: how, where, and for whom does it work? Mechanism of action, treatment targets, and individualized therapy. Curr Pharm Des (2010) 0.98
The nociceptin/orphanin FQ/NOP receptor system as a target for treatment of alcohol abuse: a review of recent work in alcohol-preferring rats. Physiol Behav (2003) 0.97
Novel therapeutic strategies for alcohol and drug addiction: focus on GABA, ion channels and transcranial magnetic stimulation. Neuropsychopharmacology (2011) 0.97
Discrete cue-conditioned alcohol-seeking after protracted abstinence: pattern of neural activation and involvement of orexin₁ receptors. Br J Pharmacol (2011) 0.97
Neuromodulatory role of the endocannabinoid signaling system in alcoholism: an overview. Prostaglandins Leukot Essent Fatty Acids (2002) 0.97
Cytoskeletal dynamics in dendritic spines: direct modulation by glutamate receptors? Trends Neurosci (1999) 0.97
Activation of brain NOP receptors attenuates acute and protracted alcohol withdrawal symptoms in the rat. Alcohol Clin Exp Res (2011) 0.96
N-Acetylcysteine reverses cocaine-induced metaplasticity. Nat Neurosci (2009) 3.49
Glutamatergic substrates of drug addiction and alcoholism. Biochem Pharmacol (2007) 3.06
Inhibition of aldehyde dehydrogenase-2 suppresses cocaine seeking by generating THP, a cocaine use-dependent inhibitor of dopamine synthesis. Nat Med (2010) 1.84
mGluR5 positive allosteric modulators facilitate both hippocampal LTP and LTD and enhance spatial learning. Neuropsychopharmacology (2009) 1.80
Potent rewarding and reinforcing effects of the synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV). Addict Biol (2012) 1.64
mGluR5 antagonism attenuates methamphetamine reinforcement and prevents reinstatement of methamphetamine-seeking behavior in rats. Neuropsychopharmacology (2008) 1.57
Positive allosteric modulation of mGluR5 receptors facilitates extinction of a cocaine contextual memory. Biol Psychiatry (2008) 1.43
The mGluR5 antagonist MPEP reduces the conditioned rewarding effects of cocaine but not other drugs of abuse. Synapse (2003) 1.41
Ethanol facilitates glutamatergic transmission to dopamine neurons in the ventral tegmental area. Neuropsychopharmacology (2008) 1.32
Decreased anxiety-like behavior, reduced stress hormones, and neurosteroid supersensitivity in mice lacking protein kinase Cepsilon. J Clin Invest (2002) 1.31
Loss of object recognition memory produced by extended access to methamphetamine self-administration is reversed by positive allosteric modulation of metabotropic glutamate receptor 5. Neuropsychopharmacology (2010) 1.25
Anxiogenic and aversive effects of corticotropin-releasing factor (CRF) in the bed nucleus of the stria terminalis in the rat: role of CRF receptor subtypes. Psychopharmacology (Berl) (2006) 1.24
Suppression of heavy drinking and alcohol seeking by a selective ALDH-2 inhibitor. Alcohol Clin Exp Res (2009) 1.13
Novel allosteric agonists of M1 muscarinic acetylcholine receptors induce brain region-specific responses that correspond with behavioral effects in animal models. J Neurosci (2012) 1.13
Role of protein kinase C epsilon (PKCvarepsilon) in the reduction of ethanol reinforcement due to mGluR5 antagonism in the nucleus accumbens shell. Psychopharmacology (Berl) (2009) 1.11
The Reinforcing and Rewarding Effects of Methylone, a Synthetic Cathinone Commonly Found in "Bath Salts" J Addict Res Ther (2012) 1.10
mGluR5 positive allosteric modulation enhances extinction learning following cocaine self-administration. Behav Neurosci (2011) 1.10
The glucocorticoid receptor antagonist mifepristone reduces ethanol intake in rats under limited access conditions. Psychoneuroendocrinology (2004) 1.06
mGluR5 receptors in the basolateral amygdala and nucleus accumbens regulate cue-induced reinstatement of ethanol-seeking behavior. Pharmacol Biochem Behav (2012) 1.05
The Effects of Maternal Separation on Adult Methamphetamine Self-Administration, Extinction, Reinstatement, and MeCP2 Immunoreactivity in the Nucleus Accumbens. Front Psychiatry (2013) 1.03
Alcohol-seeking behavior is associated with increased glutamate transmission in basolateral amygdala and nucleus accumbens as measured by glutamate-oxidase-coated biosensors. Addict Biol (2010) 1.02
Reinstatement of ethanol-seeking behavior following intravenous self-administration in Wistar rats. Alcohol Clin Exp Res (2007) 1.01
Positive allosteric modulators of type 5 metabotropic glutamate receptors (mGluR5) and their therapeutic potential for the treatment of CNS disorders. Molecules (2011) 0.99
Attenuation of methamphetamine seeking by the mGluR2/3 agonist LY379268 in rats with histories of restricted and escalated self-administration. Neuropharmacology (2012) 0.97
A role for mGluR5 receptors in intravenous methamphetamine self-administration. Ann N Y Acad Sci (2008) 0.95
The anti-relapse compound acamprosate inhibits the development of a conditioned place preference to ethanol and cocaine but not morphine. Br J Pharmacol (2003) 0.92
Effect of the mGluR5 antagonist 6-methyl-2-(phenylethynyl)pyridine (MPEP) on the acute locomotor stimulant properties of cocaine, D-amphetamine, and the dopamine reuptake inhibitor GBR12909 in mice. Psychopharmacology (Berl) (2004) 0.92
Attenuation of reinstatement of methamphetamine-, sucrose-, and food-seeking behavior in rats by fenobam, a metabotropic glutamate receptor 5 negative allosteric modulator. Psychopharmacology (Berl) (2012) 0.92
Effects of adolescent exposure to cocaine on locomotor activity and extracellular dopamine and glutamate levels in nucleus accumbens of DBA/2J mice. Brain Res (2007) 0.88
Positive Allosteric Modulation of mGluR5 Accelerates Extinction Learning but Not Relearning Following Methamphetamine Self-Administration. Front Pharmacol (2012) 0.88
The corticotropin-releasing factor/urocortin system and alcohol. Alcohol Clin Exp Res (2002) 0.88
The mGluR5 Positive Allosteric Modulator CDPPB Does Not Alter Extinction or Contextual Reinstatement of Methamphetamine-Seeking Behavior in Rats. J Addict Res Ther (2011) 0.87
Pharmacotherapies for alcoholism: the old and the new. CNS Neurol Disord Drug Targets (2010) 0.87
Role of the endogenous opioid system on the neuropsychopharmacological effects of ethanol: new insights about an old question. Alcohol Clin Exp Res (2005) 0.86
Acamprosate attenuates cocaine- and cue-induced reinstatement of cocaine-seeking behavior in rats. Psychopharmacology (Berl) (2007) 0.86
Safety and efficacy of acamprosate for the treatment of alcohol dependence. Subst Abuse (2013) 0.86
The safety of disulfiram for the treatment of alcohol and cocaine dependence in randomized clinical trials: guidance for clinical practice. Expert Opin Drug Saf (2008) 0.85
Ethanol consumption patterns and conditioned place preference in mice lacking preproenkephalin. Neurosci Lett (2002) 0.85
Changes in extracellular levels of glutamate in the nucleus accumbens after ethanol-induced behavioral sensitization in adolescent and adult mice. Alcohol (2011) 0.83
mGluR5 positive allosteric modulation and its effects on MK-801 induced set-shifting impairments in a rat operant delayed matching/non-matching-to-sample task. Psychopharmacology (Berl) (2014) 0.82
Similar ethanol drinking in adolescent and adult C57BL/6J mice after chronic ethanol exposure and withdrawal. Alcohol Clin Exp Res (2013) 0.81
Differential Modulation of Thresholds for Intracranial Self-Stimulation by mGlu5 Positive and Negative Allosteric Modulators: Implications for Effects on Drug Self-Administration. Front Pharmacol (2012) 0.80
Investigating Methamphetamine Craving Using the Extinction-Reinstatement Model in the Rat. J Addict Res Ther (2011) 0.80
Constitutive knockout of kalirin-7 leads to increased rates of cocaine self-administration. Mol Pharmacol (2013) 0.80
Intracranial stereotaxic cannulation for development of orthotopic glioblastoma allograft in Sprague-Dawley rats and histoimmunopathological characterization of the brain tumor. Neurochem Res (2007) 0.80
Ethanol pre-exposure during adolescence or adulthood increases ethanol intake but ethanol-induced conditioned place preference is enhanced only when pre-exposure occurs in adolescence. Dev Psychobiol (2012) 0.79
Early life stress and chronic variable stress in adulthood interact to influence methamphetamine self-administration in male rats. Behav Pharmacol (2016) 0.79
Combined antiretroviral therapy reduces brain viral load and pathological features of HIV encephalitis in a mouse model. J Neurovirol (2014) 0.79
Increases in doublecortin immunoreactivity in the dentate gyrus following extinction of heroin-seeking behavior. Neural Plast (2012) 0.77
Transcriptional profiling of the rat frontal cortex following administration of the mGlu5 receptor antagonists MPEP and MTEP. Eur J Pharmacol (2008) 0.77
Early-life stress interactions with the epigenome: potential mechanisms driving vulnerability toward psychiatric illness. Behav Pharmacol (2014) 0.77
NMDA Receptor Modulators in the Treatment of Drug Addiction. Pharmaceuticals (Basel) (2013) 0.77
mGlu receptors and drug addiction. Wiley Interdiscip Rev Membr Transp Signal (2012) 0.76
A microdialysis study of extracellular levels of acamprosate and naltrexone in the rat brain following acute and repeated administration. Addict Biol (2008) 0.76
The development of acamprosate as a treatment against alcohol relapse. Expert Opin Drug Discov (2014) 0.76
Neuropeptide systems and schizophrenia. CNS Neurol Disord Drug Targets (2013) 0.76
Extinction learning and adult neurogenesis. Neuropsychopharmacology (2011) 0.75
The effect of litter separation on methamphetamine-conditioned place preference in post-partum dams. Behav Pharmacol (2017) 0.75